PLUS1
5.13
0.37 (7.77%)
0.37 (7.77%)
Upgrade to Real-Time
Afterhours
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| BioCryst Pharmaceuticals Inc | BCRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.37 | 7.77% | 5.13 | 17:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 4.81 | 4.80 | 5.14 | 5.13 | 4.76 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 5.11 | 5.13 | 0.02 | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 12,032 | 3,803,628 | $ 4.95 | $ 18,832,804 | 4,538,416 | 1.58 - 6.43 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:54:22 | 49 | $ 5.12 | USD |
BioCryst Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 905.78M | 176.57M | 164.27M | $ 48.84M | $ - | -0.94 | -6.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 63.34k | 2.60% |
BioCryst Pharmaceuticals News
| Date | Time | Source | News Article |
|---|---|---|---|
| 11/20/2020 | 07:00 | GlobeNewswire Inc. | BioCryst to Present at Upcoming Virtual Investment.. |
| 11/13/2020 | 07:02 | GlobeNewswire Inc. | BioCryst Presents Data Showing Sustained Attack Rate.. |
| 11/13/2020 | 07:00 | GlobeNewswire Inc. | BioCryst Presents New Data Highlighting Burden of Therapy.. |
| 11/12/2020 | 07:00 | GlobeNewswire Inc. | BioCryst to Present Data at the 2020 ASH Annual Meeting |
| 11/05/2020 | 07:12 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 11/05/2020 | 07:00 | GlobeNewswire Inc. | BioCryst Reports Third Quarter 2020 Financial Results.. |
| 11/02/2020 | 16:15 | GlobeNewswire Inc. | BioCryst Reports Inducement Grants Under Nasdaq Listing Rule.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BCRX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.15 | 5.13 | 4.115 | 4.57 | 5,008,106 | 0.98 | 23.61% |
| 1 Month | 3.74 | 5.13 | 3.70 | 4.25 | 4,620,050 | 1.39 | 37.17% |
| 3 Months | 3.63 | 5.13 | 3.30 | 3.89 | 4,735,875 | 1.50 | 41.32% |
| 6 Months | 5.11 | 6.20 | 3.30 | 4.29 | 5,960,262 | 0.02 | 0.39% |
| 1 Year | 2.49 | 6.43 | 1.58 | 3.80 | 6,486,626 | 2.64 | 106.02% |
| 3 Years | 4.68 | 9.97 | 1.38 | 4.06 | 2,984,794 | 0.45 | 9.62% |
| 5 Years | 10.19 | 10.98 | 1.38 | 4.31 | 2,280,764 | -5.06 | -49.66% |
BioCryst Pharmaceuticals Description
| BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, with the aim of blocking key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology. |
